Medications to Reduce the Risk of Primary Breast Cancer in Women: Clinician's Guide

This guide for clinicians summarizes evidence on the effectiveness and safety of two medications used to reduce the risk of primary breast cancer: tamoxifen and raloxifene. Both of these medications are approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of primary breast cancer (defined as invasive breast cancer in women without preexisting breast cancer). However, currently they are rarely used for this purpose in the United States. This toolkit is available as PDF (requiring Adobe Reader) and as an audio file (MP3). It was developed by Agency for Healthcare Research and Quality (AHRQ), John M. Eisenberg Center at Oregon Health and Science University.

• Details
• Related Solutions

• Category: Regulatory and Accreditation Compliance Solutions

• Source: AHRQ

• Patient Care Process: Pre-care and Preventive care processes

• Setting of Care: Ambulatory/Ancillary setting

• Quality Tool Topics: Patient/Medication safety

• Stage of Care: Preventive care

• IOM Domains of Quality: Safety

• Tags: Women's Health, Oncology, Medications, Breast Cancer

	Medications to Reduce the Risk of Primary Breast Cancer in Women: Clinician's Guide This guide for clinicians summarizes evidence on the effectiveness and safety of two medications used to reduce the risk of primary breast cancer: tamoxifen and raloxifene. Both of these medications are approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of primary breast cancer (defined as invasive breast cancer in women without preexisting breast cancer). However, currently they are rarely used for this purpose in the United States. This toolkit is available as PDF (requiring Adobe Reader) and as an audio file (MP3).
	Prediction Tools These tools are a set of computerized calculators to help patients and physicians decide among the major treatment choices for several cancers. The tools can be used to predict the chance of overall survival or cancer spread or assess risk for followup treatments or cancer recurrence. The toolkit was developed by Memorial Sloan-Kettering Cancer Center. This web-based toolkit requires a web browser.
	Population Health and Environment Toolkit This toolkit was developed to assist practitioners, program managers and health conservation and development professionals interested in projects and policies that integrate community development activities with a focus on environment and health interventions in the areas of family planning, reproductive health, basic health services, education and outreach, sustainable livelihoods, coastal and natural resource management, and biodiversity conversation. Toolkit is available online through the k4health site and separated into tabs. No registration required.
	Women's Health Free Clinic Toolkit A toolkit developed by Reproductive Health Access partnered with New York City Free Clinic containing tools and suggestions on integrating comprehensive reproductive health services into an existing free clinic and modeled after the Women's Health Free Clinic that is part of the New York City Free Clinic. Toolkit is available online via click-per-links and includes links to patient education materials. No registration required.
	Hand in Hand The Hand in Hand campaign developed by Spirit Health Group® is designed to increase cancer screenings and decrease cancer deaths by raising awareness and educating American couples of the risks of gender-specific cancers and the rewards of early detection.
	Pyromaker: Online Application to Identify Gene Mutations Johns Hopkins researchers have developed an easy-to-use online computer software application that can identify meaningful gene mutations faster and at less cost than other methods currently available. The software generates simulated pyrograms, which are readouts from a gene sequencing technique known as pyrosequencing. “Pyromaker,” is available free-of-charge. A related tutorial will be posted soon.
	Guide to Preventive Cardiology for Women Developed by the American Heart Association, the Guide to Preventive Cardiology for Women is a clinical practice guideline for physicians involved in screening and treating women for heart disease. The guide includes a risk reduction plan for physicians to share with their female patients to help them prevent and treat heart disease. The guide is available as a PDF requiring Adobe Reader.
	An Employer's Guide to Cancer Treatment and Prevention Developed by the National Business Group on Health and the National Comprehensive Cancer Network, this document is a tool that aids in the planning, design, and assessment of cancer care plans. The document is available as a PDF and requires Adobe Reader.
	Breast Cancer Treatment (PDQ®) These tools and guidelines for health professionals provide comprehensive, peer-reviewed and evidence-based information about the treatment of breast cancer. The information covered includes: Incidence and Mortality, Genetic Characteristics and Risk Factors, Screening, Patient Evaluation, Prognostic and Predictive Factors, Contralateral Disease, Hormone Replacement Therapy, Breast Reconstruction and Follow-up. The toolkit is available as web pages and PDFs and requires a web browser and Adobe Reader to view them.
	The Urinary Incontinence Tool Kit This Urinary Incontinence Tool Kit was designed to help physicians with the initial evaluation of a patient with urinary incontinence. It contains educational materials, suggested guidelines, forms and tools for evaluation, diagnosis and treatment. The tool kit makes the collection of information on pattern, frequency and impact of incontinence and other background information important routine. Also included are educational materials to teach patients self-management techniques and explain medical and surgical treatment options.